Timothy Still is Accumetrics' new CEO
This article was originally published in Clinica
Platelet diagnostics firm Accumetrics has appointed Timothy Still chief executive officer, adding to his existing posts of president and chief operating officer. Mr Still has over 18 years of experience in sales, marketing and business development in healthcare and medical diagnostics. Before joining San Diego, California-based Accumetrics, he was executive vice-president and chief commercial officer for diagnostics company HemoSense (San Jose, California), which was acquired by Inverness Medical Innovations in 2007. Accumetrics' previous CEO, Steven Frankel, stepped down in September. The company markets the VerifyNow System for the assessment of platelet function in patients receiving antiplatelet therapies.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.